Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-202828
Filing Date
2024-08-19
Accepted
2024-08-19 16:21:45
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d826227d10q.htm   iXBRL 10-Q 685670
2 EX-31.1 d826227dex311.htm EX-31.1 11520
3 EX-31.2 d826227dex312.htm EX-31.2 11511
4 EX-32.1 d826227dex321.htm EX-32.1 5648
5 EX-32.2 d826227dex322.htm EX-32.2 5574
  Complete submission text file 0001193125-24-202828.txt   3802927

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240630.xsd EX-101.SCH 39384
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blacu-20240630_cal.xml EX-101.CAL 22551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240630_def.xml EX-101.DEF 185866
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240630_lab.xml EX-101.LAB 230259
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240630_pre.xml EX-101.PRE 225432
51 EXTRACTED XBRL INSTANCE DOCUMENT d826227d10q_htm.xml XML 401845
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41390 | Film No.: 241220837
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)